Cure8 research brief
Cure8 research brief
The study suggests a plant polysaccharide (from Poria cocos) can help probiotics survive and persist in the gut and may strengthen their anti-colitis effects in mice—an approach that could inform future human studies of probiotic + prebiotic combinations for IBD.
Researchers in microbiome and IBD, clinicians interested in adjunctive microbiome therapies, and patients curious about probiotic/prebiotic strategies (note: preclinical evidence only).
The research used in vitro tests and mouse models (including antibiotic-treated mice) to show that the Poria cocos polysaccharide increased probiotic proliferation, stress resistance, fecal abundance, and prolonged their persistence after stopping supplementation.
In DSS colitis models, combining the polysaccharide with the probiotic mix produced stronger anti-colitic effects than the probiotic alone; the polysaccharide by itself did not reduce colitis in antibiotic-treated mice.
The findings point to a possible prebiotic approach—pairing specific plant polysaccharides with probiotic strains—to boost probiotic persistence and therapeutic effect in experimental colitis. These results are preliminary (animal study) and do not establish safety or efficacy in people.
Results are from in vitro experiments and mouse models (including DSS colitis and antibiotic-treated mice). This is preclinical research; human studies are needed before clinical recommendations.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: Natural Science Foundation of Liaoning Province
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.